Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

17.76
Delayed Data
As of 3:59pm ET
 +0.27 / +1.54%
Today’s Change
9.09
Today|||52-Week Range
19.35
+34.24%
Year-to-Date

Today’s Trading

Previous close17.49
Today’s open17.30
Day’s range17.30 - 18.10
Volume455,717
Average volume (3 months)327,525
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-41.09%
Earnings growth (this year)+13.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.02

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.31+1.49%
TXMDTherapeuticsMD Inc+0.04+0.70%
IPXLImpax Laboratories I...+0.25+1.57%
ESPREsperion Therapeutic...+4.54+10.38%
Data as of 4:00pm ET, 06/28/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$0.00
Annual profit (last year)-$176.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Paolo Tombesi
Corporate headquarters
Bridgewater, New Jersey

Forecasts